Schedule 13G ownership disclosure
NPS PHARMACEUTICALS INC
Security class unavailable · CUSIP: 62936P103
Event date: 2015-01-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,304,540
- Percent of class
- 3.0900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-15-000023
- Form type
- SC 13G
- Filer
- NPS PHARMACEUTICALS INC
- CIK
- CIK 890465
- Filed
- Feb 10, 2015
- Reporting period
- Jan 30, 2015
- Description
- Schedule 13G beneficial ownership